Matin Shahriar 4

What Happened
Matin Shahriar, a director of KORU Medical Systems, received an award/acquisition of 3,571 shares on July 1, 2026. The shares were recorded at $4.20 each for a total value of $14,998. This was an award/grant (transaction code A), an acquisition of stock rather than a sale.

Key Details

• Transaction date and price: 2026-07-01 at $4.20 per share.
• Shares acquired: 3,571; total value: $14,998.
• Transaction type: Award/Grant (code A).
• Filing date: 2026-07-01 (filed the same day as the transaction per the Form 4).
• Shares owned after the transaction: Not disclosed in the provided filing.
• Footnotes: The filing includes a standard disclaimer that it should not be construed as an admission of beneficial ownership or filing obligation; a Power of Attorney has been previously filed. No 10b5-1 plan or tax-withholding notation is indicated in the provided details.

Context
Awards and grants are typically compensation or incentive arrangements and are an acquisition (a bullish signal is possible but not definitive). This filing documents an issuance/acquisition rather than a sale or option exercise; it does not by itself indicate trading intent or future stock moves.